After a liver transplant changed his life, UTSW postdoc is inspired to help others : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/february-liver-transplant.html
As a child in Beirut, Ahmad Anouti, M.D., endured dozens of medical procedures, hundreds of medications, and numerous setbacks before a liver transplant at age 16 saved his life
UT Southwestern stem cell biologists develop embryo model: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2023/july-embryo-model.html
UT Southwestern Medical Center biologists have innovated a new stem cell-based embryo model for studying early human development, tissue formation, and differentiation, offering valuable contributions to the field of developmental biology and regenerative medicine
UT Southwestern researcher wins NIH Director’s Award to study how DNA’s 3D structure affects health and disease: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/zhou-nih-awards.html
Jian Zhou, Ph.D., Assistant Professor in UT Southwestern’s Lyda Hill Department of Bioinformatics, has been awarded $1.5 million from the National Institutes of Health (NIH) to use artificial intelligence to investigate the three-dimensional structure of DNA and its impact on health
Honored for his work in cancer care, Dr. Johnson is himself a cancer survivor: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/david-johnson.html
Dr. David Johnson was honored as one of 15 Giants of Cancer Care at the American Society of Clinical Oncology conference in Chicago on Friday, May 30
UT Southwestern researcher wins NIH Director’s Award to study the inner workings of glial cells in the brain : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/sun-nih-awards.html
Lu Sun, Ph.D., Assistant Professor of Molecular Biology at UT Southwestern, has been awarded $1.5 million from the National Institutes of Health (NIH) to study interactions between neurons and glial cells in the brain, which could provide insight into the causes of neurological disorders
Dr. William T. Dauer selected as inaugural director of UT Southwestern’s Peter O’Donnell Jr. Brain Institute: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/dauer-obi.html
William T. Dauer, M.D., a neurologist acclaimed for his research into dystonia and Parkinson’s disease, has been selected as the first Director of the Peter O’Donnell Jr. Brain Institute at UT Southwestern Medical Center. He will begin his new position July 1
Southwestern Health Resources Accountable Care Network Listed No. 1 in U.S. for Medicare Savings: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/medicare-savings.html
SWHR ACN) saved almost $30 million in 2017, with an overall quality score of 100 percent for the fiscal year
UT Southwestern review finds hysterectomy can be avoided for common gynecological condition : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2021/hysterectomy-gynecological-condition.html
Adenomyosis – an abnormal tissue growth into the muscular wall of the uterus that causes painful cramps and heavy or prolonged menstrual bleeding – is more common than generally appreciated
Luke Perry’s death highlights need for young people to understand stroke symptoms: Newsroom, UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/luke-perry-stroke.html
Strokes are caused by sudden blockage of arteries to the brain, and they are often related to diseases such as atherosclerosis (cholesterol buildup) which worsen with age
Criteria for clinical trials might be too strict, needlessly excluding patients: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2019/clinical-trials-criteria.html
Federal regulations may keep lung cancer patients out of clinical trials simply because these patients are on medications that might affect the electrical system of the heart